Stromal fibroblasts and other cells in tumor tissues shape the immunosuppressive environment of tumors through TGFβ signaling, inhibiting the antitumor activity of immune cells and preventing or weakening the effect of anticancer immunotherapy (57). Here, TGFB1 is linked to neoplasm.